Bundling…..Will we survive? Thomas E. Amitrano BSN, MPA, RN.

Slides:



Advertisements
Similar presentations
Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access Theodore F. Saad, MD Nephrology Associates, PA Christiana Care Health.
Advertisements

The Medicare Modernization Act: One step forward or two steps back? Allen R. Nissenson MD Professor of Medicine Director, Dialysis Program David Geffen.
Robert Hootkins MD PhD FASN An Assist from: Alex Rosenblum RN, AM & FM Jay Wish MD Steven Fishbane MD.
Renal Replacement Therapy: What the PCP Needs to Know.
A New Professional Expectation Nurse Participation in Health Policy: The End Stage Renal Disease (ESRD) Program Case Study Kathryn Taylor, RN December.
“Hospital Uncompensated Care Issues” Teresa Coughlin, M.P.H. Senior Research Associate The Urban Institute.
Delivery System Reform Incentive Payment Pool (DSRIP) March 14, 2013.
1115 WAIVER Utah Department of Health Division of Medicaid and Health Financing 1Chacon.
All Payer Claims Database APCD Databases created by state mandate, that includes data derived from medical, eligibility, provider, pharmacy and /or dental.
Vol 2, ESRD, Ch ANNUAL DATA REPORT VOLUME 2: END-STAGE RENAL DISEASE Chapter 9: Costs of ESRD.
FFBI Change Concepts FFBI Change Concept #12 Presented by: Ellen DePrat, MSN, RN, NE, CPHQ Project Coordinator - HealthInsight (QIO for Nevada/Utah) October.
The State of CKD, ESRD and Mortality in the First Year on Dialysis: Are We Doing Enough? Allan J. Collins, MD, FACP Professor of Medicine University of.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
The EMR Puzzle – Putting the Pieces Together March 10, 2015.
Health Center Revenue and Reimbursement Management
Dialysis Facility Compare Valarie Ashby Co-Managing Director UM-KECC.
DIVISION OF HEALTH CARE FINANCING & POLICY Patient Protection and Affordable Care Act Provider-Preventable Conditions.
Present on Admission. Requirements of Deficit Reduction Act 2005 CMS and CDC choose conditions that are: High Cost, High Volume, or both. Assigned to.
Kidney Diseases Prevention. Overview The mortality rate of Nephritis, Nephrotic Syndrome, and Nephrosis (18.15 per 100,000 population) marching the 7th.
HEALTH AND PRODUCTIVITY MANAGEMENT H P M THINK GLOBALLY! BY: BRIAN D. HARRISON, MD DATE:9/28/04.
Infections in the dialysis population: A major communicable disease issue! Allan J. Collins, MD, FACP Professor of Medicine University of Minnesota Director,
Copyright © 2008 Delmar Learning. All rights reserved. Chapter 9 CMS Reimbursement Methodologies.
Health Care Reform Quynh Smith. Sources of Inefficiency in the Health Care Delivery System   We spend a substantial amount on high cost, low-value treatments.
Population Health John Studebaker, MD, MS Forward Health Group, Inc.
1 Strategies Today for Higher Quality Tomorrow Brady Augustine Senior Executive for ESRD Program & Acting Director, DCCP March 25, 2004.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
INFLUENCE OF MEANINGFUL USE AMONG HEALTHCARE PROVIDERS Neely Duffey, Olivia Mire, Mallory Murphy, and Dana Sizemore.
Objectives Identify the PPS base rate for 2016
Health Care Reform April 28 & 29, 2010 Jack A. Lenhart, M.D. Medical Director, Valley Preferred Jack A. Lenhart, M.D. Medical Director, Valley Preferred.
© 2015 TriZetto Corporation ICD-10: Ready, Set, Go! August 27, 2015.
Linda Steffens BSN RN CCRN Stacy Jaeger MS APRN-BC Susan Herrmann MSN RN Kimberly Thomas BSN RN MSM CCRN Katherine Barker MSN RN MSRN CPN Audrey Eggleston.
Arizona Health Care Cost Containment System DRG-Based Inpatient Hospital Payment System Project Overview June 14, 2012.
“Reaching across Arizona to provide comprehensive quality health care for those in need” AHCCCS Transition to Inpatient DRG Payment Methodology.
The Changing Reimbursement System: Interaction Between Medicare Part B and Medicare Part D The intersection of business strategy and public policy.
Healthy People 2010 Focus Area 4
A Comparison of Sevelamer and Calcium-Based Phosphate Binders on Mortality, Hospitalization, and Morbidity in Hemodialysis: A Secondary Analysis of the.
The Medicare crisis: What does it mean for nephrology care? Allen R. Nissenson MD Professor of Medicine Director, Dialysis Program David Geffen School.
Physicians and Health Information Exchange (HIE) The Value of HIE to a Physician’s Practice and Consumers.
Improving Value in Health Care: Challenges and Potential Strategies Arnold M Epstein October 24, 2008 Congressional Health Care Reform Education Project.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 11: Costs of ESRD.
NORTHERN MICHIGAN HEMODIALYSIS RESOURCE CENTER MARIANNA BURNS MARY HAVERTY-ROBINSON MARIANNE LANNEN JENNIFER SMITH RIKKI ZISSLER Northern Michigan Hemodialysis.
Health Insurance Plans 2.4 Cost is a major concern Health care is over 15% of the gross national product Without insurance the cost of an illness can become.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 4: Vascular Access.
2009 Standardized Mortality Ratio Project: Summary Svetlana (Lana) Kacherova, QI Director Lisle Mukai, QI Coordinator ESRD Network 18 July 21, 2009.
Changes in ESRD Medicare Reimbursement: What The Patient Needs to Know Jay Wish, MD Medical Director, Dialysis Program University Hospitals Case Medical.
Moving Toward HITECH Healthcare EHR Adoption at the Dawn of a New Era
/ ©2015 NAVIGANT CONSULTING, INC. ALL RIGHTS RESERVED 1 TERRANCE GOVENDER MD CLINICAL DOCUMENTATION INTEGRITY.
Preemptive Kidney Transplant (PKT) – the Optimal Therapy in ESRD Reference: Connie L. Davis. Preemptive transplantation and the transplant first initiative.
USRDS USRDS 2002 adr Period prevalent ESRD patient, deaths, & ESRD expenditures figure 12.1.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
If It’s JULY, It’s RULE TIME!
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
Figure 11.1 Trends in ESRD expenditures,
Volume 2: End-Stage Renal Disease
2017 Annual Data Report Healthy People 2020.
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Chapter 9: Healthcare Expenditures for Persons with ESRD
DECREASING HOSPITALIZATIONS IN DIALYSIS PATIENTS
2:4 Health Insurance Plans
CHAPTER 5 Paediatric Renal Replacement Therapy
2018 Annual Data Report Volume 3: Healthy People 2020
Chapter 9: Healthcare Expenditures for Persons with ESRD
Value-Based Healthcare: The Evolving Model
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Transforming Perspectives
Restructuring the ESRD payment system in the United States
Presentation transcript:

Bundling…..Will we survive? Thomas E. Amitrano BSN, MPA, RN

Bundling…..Will we survive?

Bundling How Will We Survive ?

A bit of History In 1972 Congress enacted legislation to create a way to finance End Stage Renal Disease (ESRD) In 1972 Congress enacted legislation to create a way to finance End Stage Renal Disease (ESRD) In 2008 Congress passed the Medical Modernization Act (MMA) as well as the Medicare Improvements for Patients and Providers Act (MIPPA) these acts required the Centers for Medicare and Medicaid Services (CMS) to look at the elimination of payments that were separately paid for dialysis services and drugs. In 2008 Congress passed the Medical Modernization Act (MMA) as well as the Medicare Improvements for Patients and Providers Act (MIPPA) these acts required the Centers for Medicare and Medicaid Services (CMS) to look at the elimination of payments that were separately paid for dialysis services and drugs. Bundling is the solution CMS has proposed Bundling is the solution CMS has proposed

Estimated point prevalent ESRD patients Figure 11.3 (Volume 2) December 31 point prevalent ESRD patients; non-Medicare status determined from payor sequence. USRDS 2009 ADR

Total Medicare dollars spent on ESRD, by type of service Figure 11.5 (Volume 2) ESRD spending obtained from Medicare ESRD claims, & includes all Medicare as primary payor claims as well as amounts paid by Medicare as secondary payor. USDRS 2009 ADR

Total Medicare ESRD expenditures, by modality Figure 11.6 (Volume 2) Period prevalent ESRD patients. Modalities determined using Model 1 methodology. Includes Medicare paid claims for ESRD patients, starting at first ESRD service date & continuing until death or the end of the study period. Patients with Medicare as secondary payor are included. USRDS 2009 ADR

Total Medicare spending on injectables Figure (Volume 2) Period prevalent dialysis patients.. ESAs: erythropoiesis stimulating agents. USRDS 2009 ADR

Why change? In a separately billable system certain services are billed for as “composite” and others are billed for as “separately billable”. This system left some question as to the profit margin some dialysis units reported. If all services were equal why did some units make more money than others? In a separately billable system certain services are billed for as “composite” and others are billed for as “separately billable”. This system left some question as to the profit margin some dialysis units reported. If all services were equal why did some units make more money than others?

Proposed* Changes Payment will be on a per treatment basis Payment will be on a per treatment basis All drugs and labs will be included All drugs and labs will be included –All renal service oral drugs including Phosphorus binders –All labs ordered by Nephrologists or others Reimbursement would “trim 2% of the estimated payments that would have been made in 2011 under the previous payment system” Reimbursement would “trim 2% of the estimated payments that would have been made in 2011 under the previous payment system” No adjustment for Race/Ethnicity No adjustment for Race/Ethnicity Wage Index Adjustments are likely Wage Index Adjustments are likely

Proposed* Changes (con’t) Units will have the option of easing in over 4 years or going 100% at one time Units will have the option of easing in over 4 years or going 100% at one time The Math…… The Math…… –2007 claims data proposed the 2011 rate would be $ – CMS is proposing a 21.73% reduction = $ –Proposed Outlier Adjustment 1% reduction = $ –MIPPA required a 98% reduction = $198.64

Problems Old data may have been used – cost reports etc. in some cases are dated Old data may have been used – cost reports etc. in some cases are dated No consideration of inflation No consideration of inflation Certain areas of the country will get less reimbursement for the same services Certain areas of the country will get less reimbursement for the same services Potential for decreased care based on decreased reimbursement exists Potential for decreased care based on decreased reimbursement exists

New Quality Indicators on or after July 1,2010 Kt/V must be reported for both HD and PD Kt/V must be reported for both HD and PD Access type must be reported for HD Access type must be reported for HD –Modifier V5: Vascular Catheter –Modifier V6: Arteriovenous Graft –Modifier V7: Arteriovenous Fistula –Modifier V8: Infection present –Modifier V9: No Infection present

Worries/ Concerns Will Practice be a result of Payment Will Practice be a result of Payment Will Quality and Performance Improvement Change Will Quality and Performance Improvement Change Will Hospitalizations be decreased or shortened for the wrong reasons Will Hospitalizations be decreased or shortened for the wrong reasons Will units close and leave gaps in service Will units close and leave gaps in service Will we have to do more with less Will we have to do more with less

Our Role in Bundling Maintain high standards of care Maintain high standards of care Encourage each patient to maintain their optimal level of health Encourage each patient to maintain their optimal level of health Educate patients to be proactive and preventative not reactive regarding their health Educate patients to be proactive and preventative not reactive regarding their health Work diligently to prevent patient illness Work diligently to prevent patient illness

Our Role in Bundling (con’t) Accurately document all information on all forms….. co morbid conditions are important Accurately document all information on all forms….. co morbid conditions are important Look for ways to improve efficiency Look for ways to improve efficiency Make patient safety and well being a major priority and goal Make patient safety and well being a major priority and goal –Decrease hospitalizations –Decrease infections –Manage medications

Our Role in Bundling (con’t) Remain in close communication with the Hospital Dialysis Units maintain continuity thru the continuum of health/illness Remain in close communication with the Hospital Dialysis Units maintain continuity thru the continuum of health/illness Develop Policies and Practices that are evidence based to ensure high standards Develop Policies and Practices that are evidence based to ensure high standards “No missed Treatment” philosophy offer alternate times/days “No missed Treatment” philosophy offer alternate times/days

Planning for Change Assess current practices and critically analyze the ability of the practice to survive Assess current practices and critically analyze the ability of the practice to survive Develop strategies that promote patient well being across the continuum of health Develop strategies that promote patient well being across the continuum of health Incorporate Evidence Based Practice into Policies and Practices Incorporate Evidence Based Practice into Policies and Practices

Planning for Change (con’t) Analyze QAPI data for trends and patterns Analyze QAPI data for trends and patterns –Deming cycle

Planning for Change (con’t) Read, Read, Read Read, Read, Read Actively engage your colleagues in a Spirit of Change Actively engage your colleagues in a Spirit of Change –Buy in on all levels will be critical –Team work is essential to success –Embrace the opportunity to help your unit succeed

Summary Bundling is going to happen in some form Bundling is going to happen in some form We will need to be ready in some way We will need to be ready in some way We will all be effected some how We will all be effected some how We can all do something to prepare for the change We can all do something to prepare for the change –Review practice –Educate patients –Set high Standards

Resources